Skip to content

More evidence that antiretrovirals reduce the risk of non-HIV illnesses at lower CD4 cell counts

Discrimination and distrust not sufficient to explain racial differences in adherence: US study

New UK guidelines recommend normalisation of HIV testing in a wide range of healthcare settings

New maturation inhibitor ready for trials in HIV-positive patients

Switching to AZT from d4T poses challenges in resource-limited settings

PrEP could be cost-effective and avert infections in high-risk MSM: model

HIV treatment at same time as TB treatment halves death rate in South African study

Survey shows less than 25% getting ARVS in many countries, despite growth in international funding

MDR-TB may be more infectious, study of HIV patients finds